• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Pharmacy HIT Integration: Building a Roadmap

Article

Shelly Spiro, RPh, FASCP, Director of the Pharmacy e-Health Information Technology Collaborative, provided an overview of pharmacy Health Information Technology (HIT) during her presentation The Roadmap for Pharmacy HIT Integration on Friday.

Shelly Spiro, RPh, FASCP, Director of the Pharmacy e-Health Information Technology Collaborative, provided an overview of pharmacy Health Information Technology (HIT) during her presentation “The Roadmap for Pharmacy HIT Integration” on Friday at the Academy of Managed Care Pharmacy (AMCP) 24th Annual Meeting.

The Roadmap is an expansive document developed by members of the Pharmacy e-HIT Collaborative—an organization founded by 9 national pharmacy organizations representing more than 250,000 members in all practice settings—that provides guidance to policymakers, provider organizations, vendors, and payers who are involved in the integration of pharmacy HIT. Out of the 10 defined goals, three are focused on outlining the adoption of electronic health records (EHRs) by pharmacists to ensure safe and effective use of medication; achieve integration of clinical data with e-prescribing systems; and advocate pharmacist recognition in existing programs and policies.

Next steps will involve a survey to rank and prioritize the 10 goals and to convene a focus group. The objective of the focus group will be to work on action plans to achieve the objectives and strategies outlined in the Roadmap. The Collaborative will begin to work on the objectives and strategies that fall under the Collaborative scope. Pharmacists are encouraged ot get involved by discussing the adoption of pharmacist EHR functionality with pharmacy management system vendors; taking an inter-professional team approach to EHR adoption in all practice settings; and participate in HIT initiatives with professional associations.

For more information on this and other sessions, please visit www.amcp.org.

Related Videos
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Dan Nardi
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.